Events

Educational Webinar Series – Five Years Since Azedra FDA Approval: What Have We Learned?

July 18, 2023

Azedra was approved by the Food and Drug Administration (FDA) five years ago. What have we learned through research since that time? Who is a good candidate for this treatment? How is it administered, and what are the side effects? OSU’s Dr. Vineeth Sukrithan joins us on Tuesday, July 18th at 12 PM PT/3 PM ET for an in-depth look at the first drug developed specifically for the treatment of pheochromocytoma and paraganglioma, and how it’s used in a clinical setting.

Five Years Since Azedra FDA Approval: What Have We Learned?

Register below!
  • This field is for validation purposes and should be left unchanged.